search
Back to results

Optimizing the Previs Device for Prediction of Postoperative Ileus

Primary Purpose

Ileus

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Entac Medical device application
Patient Daily Assessment
Patient Discharge Assessment
Sponsored by
Jennifer Hrabe
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Ileus focused on measuring Ileus, Abdominal surgery, Bowel obstruction, Postoperative Ileus

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patients undergoing elective intestinal resection surgery by the colorectal surgery service at UIHC.

Age 18 to 100.

Exclusion Criteria:

Allergies to any of the device components. Inability to have prototype device applied to their abdominal wall due to a condition (ie:fistulas, stomas, drains, etc).

Sites / Locations

  • University of IowaRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Study Participants

Arm Description

Device: Entac Medical device application Other: Patient Daily Assessment Other: Patient Discharge Assessment

Outcomes

Primary Outcome Measures

Maximize the predictive value of the device for predicting postoperative GI impairment.
The signal processing algorithm will be modified iteratively to maximize the negative predictive value of the device while maintaining the highest PPV The sensitivity, specificity, positive predictive value, negative predictive value, AUC, and accuracy of the device for each 10-30 patients (dependent upon the incidence of GI impairment in each group) will be measured. The signal processing algorithm will be modified iteratively to maximize the negative predictive value of the device while maintaining the highest PPV possible. Our goal is for the AUC for the final algorithm to be greater than 0.8.

Secondary Outcome Measures

Full Information

First Posted
April 11, 2018
Last Updated
September 24, 2023
Sponsor
Jennifer Hrabe
search

1. Study Identification

Unique Protocol Identification Number
NCT03505476
Brief Title
Optimizing the Previs Device for Prediction of Postoperative Ileus
Official Title
Optimizing the Previs Device for Prediction of Postoperative Ileus
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 24, 2018 (Actual)
Primary Completion Date
May 2025 (Anticipated)
Study Completion Date
December 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jennifer Hrabe

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The research proposed in this study will develop a noninvasive prototype device that will capture intestinal sounds, process signals, and display predictive information in real-time at the point-of-care using algorithms already developed at this institution.
Detailed Description
Following major abdominal surgery, up to 30% of patients develop a poorly understood condition known as ileus. When ileus occurs, the bowels shut down and patients often develop abdominal dissension, nausea, vomiting, and even more serious complications. Because this condition does not develop until many days after surgery has been completed, clinicians do not know if they should begin allowing patients to eat or withhold nutrition until they show signs of bowel function such as passing gas or having bowel movements. Clinicians have different approaches but none are ideal: 1) feed all patients early and the ones that develop an ileus will have their diets reverse, suction tube placed in their stomach, and hopefully don't get develop more serious complications, or 2) don't feed patients until they pass gas or have a bowel movement, which delays nutrition and prolongs hospital stays for the 70% of patients who will not develop an ileus Participants in this study will be asked to wear a 3-ounce device that adheres to the skin of the abdominal wall for 10 days. They will also be asked to answer questions each day of their hospital stay regarding how they have tolerated eating.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ileus
Keywords
Ileus, Abdominal surgery, Bowel obstruction, Postoperative Ileus

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
All subjects consented and enrolled will receive the same intervention. There is no control group.
Masking
None (Open Label)
Allocation
N/A
Enrollment
225 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Study Participants
Arm Type
Experimental
Arm Description
Device: Entac Medical device application Other: Patient Daily Assessment Other: Patient Discharge Assessment
Intervention Type
Device
Intervention Name(s)
Entac Medical device application
Intervention Description
Subjects will wear a 3-inch by 3-inch stethoscope device that adheres to the skin of the abdomen via FDA approved adhesive material. It will be applied either in the operating room at the completion of surgery or in the recovery room. The device will remain on the abdomen until discharge or for 10 days, whichever comes first.
Intervention Type
Other
Intervention Name(s)
Patient Daily Assessment
Intervention Description
The research team will ask questions of the subject regarding nausea, vomiting, passage of flatus, return of bowel function, and satisfaction with the device every day that the subject is hospitalized.
Intervention Type
Other
Intervention Name(s)
Patient Discharge Assessment
Intervention Description
The research team will ask questions of the subject regarding satisfaction or dissatisfaction with having the device placed and attached to their abdomen.
Primary Outcome Measure Information:
Title
Maximize the predictive value of the device for predicting postoperative GI impairment.
Description
The signal processing algorithm will be modified iteratively to maximize the negative predictive value of the device while maintaining the highest PPV The sensitivity, specificity, positive predictive value, negative predictive value, AUC, and accuracy of the device for each 10-30 patients (dependent upon the incidence of GI impairment in each group) will be measured. The signal processing algorithm will be modified iteratively to maximize the negative predictive value of the device while maintaining the highest PPV possible. Our goal is for the AUC for the final algorithm to be greater than 0.8.
Time Frame
Each patient's data will be evaluated after 14 days. Each group of 10-30 patients' data will be analyzed. Final analysis will occur after 225 patients are enrolled.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients undergoing elective intestinal resection surgery by the colorectal surgery service at UIHC. Age 18 to 100. Exclusion Criteria: Allergies to any of the device components. Inability to have prototype device applied to their abdominal wall due to a condition (ie:fistulas, stomas, drains, etc).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Debra OConnell Moore, MBA
Phone
319-356-1693
Email
debra-oconnell-moore@uiowa.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Jessica Danielson
Phone
319-356-1722
Email
jessica-danielson@uiowa.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer Hrabe
Organizational Affiliation
University of Iowa
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Iowa
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessica Danielson
Phone
319-356-1722
Email
jessica-danielson@uiowa.edu
First Name & Middle Initial & Last Name & Degree
Kimberly Sprenger
Phone
319-353-8862
Email
kimberly-sprenger@uiowa.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Optimizing the Previs Device for Prediction of Postoperative Ileus

We'll reach out to this number within 24 hrs